Home › Funds › ORBIMED ADVISORS LLC › UPB

ORBIMED ADVISORS LLC position in UPB

UPSTREAM BIO INC · Health Care

ORBIMED ADVISORS LLC reported holding 5,693,589 shares of UPB (UPSTREAM BIO INC) in its Q2 2026 13F filing — a position valued at US$39.4M, representing 0.79% of its reported portfolio and ranking #36 among its reported holdings. ORBIMED ADVISORS LLC has disclosed UPB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)5.69M sh
Reported value held$39.40M
Portfolio Weight0.79%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's UPB position evolved

ORBIMED ADVISORS LLC first disclosed a stake in UPB in Q4 2024 at 5,693,589 shares (US$93.6M). The position peaked in Q4 2025 at 5,693,589 shares, worth US$154.6M. Across 7 filings, ORBIMED ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,693,589 shares valued at US$39.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 5.69M $93.60M New
Q1 2025 5.69M $34.84M Hold
Q2 2025 5.69M $62.52M Hold
Q3 2025 5.69M $107.10M Hold
Q4 2025 5.69M $154.58M Hold
Q1 2026 5.69M $51.24M Hold
Q2 2026 5.69M $39.40M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UPB and 13F data

UPB (UPSTREAM BIO INC) is a Health Care company. 56 other funds we track also report a position in UPB — the largest reported positions include Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M), Parkman Healthcare Partners LLC (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UPB

All UPB fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held UPB?

ORBIMED ADVISORS LLC has disclosed UPB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is ORBIMED ADVISORS LLC's current position in UPB?

As of Q2 2026, ORBIMED ADVISORS LLC holds 5.69M shares of UPB (UPSTREAM BIO INC), valued at $39.40M, representing 0.79% of its reported portfolio and ranking #36.

Has ORBIMED ADVISORS LLC been buying or selling UPB?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in UPB. The position peaked in Q4 2025 at 5.69M shares.

Which other funds hold UPB?

Other major institutional holders of UPB include Decheng Capital LLC, Enavate Sciences GP, LLC, Parkman Healthcare Partners LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.